November 12th, 2026Retatrutide Phase 3 Trials Report Reduced Knee Osteoarthritis PainRetatrutide trials report less knee osteoarthritis pain; ixekizumab plus tirzepatide shows exploratory ACR50 benefits in psoriatic arthritis.Read more
October 6th, 20269 Drugs Approved for Primary Care: Q3 2026Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.Read more